Sponsor Pipeline

National Research Center for Hematology, Russia Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
2
Phase 3
5
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06188676 Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in… Primary Mediastinal Lymphoma Recruiting
NCT06418776 IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML Refractory Acute Myeloid Leukemia Recruiting
Phase 2
NCT07209059 PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma Hodgkin Lymphoma Recruiting
Not specified
NCT06237192 MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute… Precursor Cell Lymphoblastic Leukemia-Lymphoma Recruiting
NCT06721598 An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in… Non-Hodgkin Lymphoma, B-cell Not Yet Recruiting
Disease Areas
Leukemia (3) Acute Myeloid Leukemia (AML) (1) Acute Lymphoblastic Leukemia (ALL) (1) Non-Hodgkin Lymphoma (1) Hodgkin Lymphoma (1)
Get alerts when National Research Center for Hematology, Russia's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free